Abstract
ABSTRACT: Defects in pyruvate dehydrogenase, the first catalytic component of the pyruvate dehydrogenase complex, are the most common cause of pyruvate dehydrogenase complex deficiency. A family with variable pyruvate dehydrogenase complex deficiency had been described in which cultured skin fibroblasts of affected family members had normal pyruvate dehydrogenase complex activity, but different tissues and blood lymphocytes had significantly diminished activities. Enzymatic activity and immunoblot studies indicated that pyruvate dehydrogenase was affected. Further evidence is presented here showing that the defect affecting pyruvate dehydrogenase complex activity is posttranscriptional. Sequencing of the coding region of the α-subunit of pyruvate dehydrogenase revealed a point mutation in the codon for amino acid 234 resulting in a substitution of glycine for arginine. Study of other members of the family suggested that this mutation is inherited in a sex-linked mode. The point mutation is located in a highly conserved region of the pyruvate dehydrogenase α-subunit gene that contains both hydrophobic and positively charged amino acid residues. Variable expression of pyruvate dehydrogenase complex deficiency in this case may be due to instability of the pyruvate dehydrogenase heterotetramer in specific tissues because of a disruption in subunit-subunit interaction.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wexler, I., Hemalatha, S., Liu, TC. et al. A Mutation in the E1α Subunit of Pyruvate Dehydrogenase Associated with Variable Expression of Pyruvate Dehydrogenase Complex Deficiency. Pediatr Res 32, 169–174 (1992). https://doi.org/10.1203/00006450-199208000-00009
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1203/00006450-199208000-00009
This article is cited by
-
Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-term survival
Human Genome Variation (2017)
-
A cognitively normal PDH‐deficient 18‐year‐old man carrying the R263G mutation in the PDHA1 gene
Journal of Inherited Metabolic Disease (2009)
-
In obese individuals dexfenfluramine corrects molecular derangements reflecting insulin resistance
International Journal of Obesity (2000)
-
Characterization of a point mutation in the pyruvate dehydrogenase E1α gene from two boys with primary lactic acidaemia
Journal of Inherited Metabolic Disease (1994)